Dossier · REAL · Dormant
REAL · The RealReal, Inc. · Stock research
Last analysed ·
Current thesis
The 2026-08-06 binary resolved bullish — record GMV $617M (+22%), adj EBITDA $13.5M at a 7.0% margin, FY GMV guide lifted to $2.535–2.565B — and the tape did not re-rate: $11.40 on 2026-08-14 versus ~$11.37 on 2026-07-23, still 32.5% under the 52-week high. Fundamentals accelerating, price flow moderating, ~$13 shelf unbroken, and no company catalyst until the Q3 print.
Kill line
A weekly close below $10.00 gives back the ground held through the beat-and-raise and breaks the recovery structure off the sub-$5 low; secondary condition is the Q3 print (~2026-11-05, est.) cutting the FY2026 adjusted-EBITDA range of $66–69M or landing GMV under the $610M low end of guide.
Pick status
Open commitment scored if the kill line above fires How this is scored →Latest analysis and events for REAL —
As of 16 August 2026, the latest FrontierPicks analysis for The RealReal, Inc. (REAL): The 2026-08-06 binary resolved bullish — record GMV $617M (+22%), adj EBITDA $13.5M at a 7.0% margin, FY GMV guide lifted to $2.535–2.565B — and the tape did not re-rate: $11.40 on 2026-08-14 versus ~$11.37 on 2026-07-23, still 32.5% under the 52-week high. Fundamentals accelerating, price flow moderating, ~$13 shelf unbroken, and no company catalyst until the Q3 print.
Kill line: A weekly close below $10.00 gives back the ground held through the beat-and-raise and breaks the recovery structure off the sub-$5 low; secondary condition is the Q3 print (~2026-11-05, est.) cutting the FY2026 adjusted-EBITDA range of $66–69M or landing GMV under the $610M low end of guide.
Current Thesis
The narrative leg on offer is a luxury-consignment turnaround that has crossed from "profitable in adjusted terms" into "profitable and compounding at scale." The 2026-08-06 Q2 print delivered every piece of that: GMV $617M (+22% YoY), an all-time quarterly high and the fourth straight quarter of GMV growth above 20%; revenue $192.6M against $188.1M consensus; adjusted EPS $(0.01) versus $(0.02) estimated; adjusted EBITDA $13.5M at a 7.0% margin, up roughly 290bps YoY. Management raised FY2026 GMV to $2.535–2.565B (19–20% growth) and revenue to $788–797M from $770–784M, and set FY adjusted EBITDA at $66–69M.
What did not happen is the re-rate. The 2026-08-14 close of $11.40 sits essentially where the shares traded before the print (~$11.37 on 2026-07-23) and 32.5% below the $16.90 52-week high, with RSI(14) at 46.8. A beat-and-raise absorbed without price expansion is the defining fact of this refresh. The operating story is accelerating; the narrative, measured by who is showing up to buy it, is maturing — well known, still working, moderating flow.
Bullish and bearish views on The RealReal, Inc.
The model's bull view on The RealReal, Inc. (REAL), in brief: Q2 2026 (2026-08-06): GMV $617M, +22% YoY, all-time quarterly high; fourth consecutive quarter above 20% GMV growth. The bear view: The catalyst came and went. Between the 2026-07-23 close (~$11.37) and 2026-08-14 ($11.40), the market was handed a record GMV quarter, a revenue beat and a guidance raise, and paid nothing for it. Absent a bid, the $13 range top stays a ceiling regardless of the operating… Both cases follow in full.
Bull Case
- Q2 2026 (2026-08-06): GMV $617M, +22% YoY, all-time quarterly high; fourth consecutive quarter above 20% GMV growth. The growth line is not a single-quarter artifact.
- Adjusted EBITDA $13.5M, margin 7.0% versus 4.1% a year earlier — margin expansion running alongside 20%+ top-line growth rather than instead of it.
- FY2026 guidance raised on 2026-08-06 to GMV $2.535–2.565B and revenue $788–797M, up from the $770–784M revenue range; the May 7 raise took GMV to $2.39–2.45B, so this is the second upward revision of 2026.
- Q3 2026 guide set at GMV $610–620M, revenue $194–198M (versus $190.97M consensus), adjusted EBITDA $13.5–14.5M — a bar the company put in writing rather than left to the street.
- Unit economics moved the right way: TTM active buyers 1,107,000 (+11% YoY), orders 937,000, AOV $659 (+13% YoY). Buyer count and basket size are both contributing.
- Sell-side raised into the print rather than fading it: UBS to $16 (Neutral, 2026-08-07), Baird to $15 from $13, Roth Capital to $19 from $17. Investing.com's 8-analyst consensus shows an average target of $18.19 with a $16 low and $20 high — every published target in that range sits above the 2026-08-14 close of $11.40.
Bear Case
- The catalyst came and went. Between the 2026-07-23 close (~$11.37) and 2026-08-14 ($11.40), the market was handed a record GMV quarter, a revenue beat and a guidance raise, and paid nothing for it. Absent a bid, the $13 range top stays a ceiling regardless of the operating trajectory.
- GAAP has not converged: Q2 net loss was $(27)M against +$13.5M adjusted EBITDA. The gap is not decomposed here, and it is the lever every bear pulls.
- Capital structure: $231.5M of convertible senior notes against $119.1M cash and equivalents as of Q2 2026. That constrains how much of the EBITDA improvement accrues to equity.
- Gross margin was 74.4%, only +10bps YoY, while direct revenue grew 26% versus consignment revenue at 15%. Mix is shifting toward the lower-margin line; the margin story is currently opex leverage, not gross-margin gain.
- INFERRED, not reported: with Q1 adjusted EBITDA near $13.1M, Q2 at $13.5M and Q3 guided to $13.5–14.5M, the FY2026 $66–69M range leans on a Q4 materially larger than anything printed in 2026 so far. Holiday seasonality supports that, but it makes the FY number back-loaded and therefore the single most cuttable line in November.
- Q3 GMV guidance of $610–620M brackets the $617M Q2 actual — sequential flatness at the midpoint, in a business the bulls are underwriting for compounding.
- Luxury demand remains macro-linked. Soft primary-luxury reads can cut both ways (more consignment supply, weaker buyer wallet), and competition from Vestiaire Collective, Fashionphile, StockX, ThredUp and brand-run resale caps take-rate power.
Setup & Price Structure
- Reference close 2026-08-14: $11.40. 52-week high $16.90, leaving price 32.5% below it. Three-month return +25.8%. RSI(14) 46.8 — mid-range, no momentum extension to unwind.
- The structure is still the consolidation described in prior coverage, not a base breakout. The ~$13 area remains the unbroken range top; the post-print behaviour is a hold in the low $11s rather than an advance.
- Crowding observables, stated as observables: sell-side is uniformly positive with a Strong Buy consensus and every target above the tape, which is a one-sided analyst book, while RSI at 46.8 and a price a third below the 52-week high show no momentum-crowding by the usual distance-above-a-rising-average measure. Those two point in opposite directions.
- Insider evidence does not show distribution into strength. The 2026 Form 4 flow found in the record is automatic tax-withholding on vesting — No discretionary open-market officer selling surfaced in that window.
- With the earnings binary behind it and roughly eleven weeks until the next scheduled company event, the tape has no dated forcing function. Rangebound consolidation is the base case for the interval, and a mid-range entry carries the time cost of that.
Catalyst Calendar (next 30 days)
- 2026-08-16 to 2026-09-15: no confirmed company-dated catalyst. The Q2 call was held 2026-08-06 and no September investor-conference appearance has been announced as of this writing.
- ~2026-11-05 (est.): Q3 2026 print. Q2 was reported 2026-08-06 and Q1 on 2026-05-07, so early November is the pattern-implied date, not a confirmed one. The checkable bar is already public: GMV $610–620M, revenue $194–198M, adjusted EBITDA $13.5–14.5M, and the FY2026 GMV $2.535–2.565B / revenue $788–797M / adjusted EBITDA $66–69M ranges reiterated or moved.
- Undated within the window: European luxury-house autumn sales updates feed the demand read-through, but no confirmed date is available to publish here.
What Would Change Our Mind
The break is not a headline — it is the market repeatedly declining to pay for a raised guide. If a second beat-and-raise passes and the ~$13 shelf still caps price, the durable-profitability leg is not being underwritten by the marginal buyer and the name is a value trap with good slides. Concretely: a weekly close below $10.00 gives back everything held through the print and breaks the recovery structure off the sub-$5 low. On the fundamental side, a Q3 print that trims the FY2026 adjusted-EBITDA range of $66–69M, or lands GMV under the $610M low end of the Q3 guide, would mark the fourth-consecutive-20% GMV streak as the peak rather than the run rate. The reverse also applies: a weekly close above $13 on expanding volume would convert this from a rangebound turnaround into a fresh trend leg, and the sell-side target cluster from $16 to $20 becomes the reference band rather than a decoration.
Watch also for target cuts. The published range currently bottoms at $16; a desk moving below $13 would signal that the analyst book — the one constituency still fully committed — is de-rating.
Correlation Notes
- Trades as a small-cap consumer-discretionary marketplace: highest correlation to online-resale and marketplace peers (ThredUp, eBay's authenticated-luxury business) and to Russell 2000 risk appetite generally, rather than to the primary-luxury complex.
- Read-through from LVMH, Kering and Richemont is two-sided: weak primary luxury increases consignment supply while pressuring buyer demand, so a soft European luxury tape is not a clean negative signal for GMV.
- $231.5M of convertible notes against $119.1M cash makes the equity sensitive to credit conditions and refinancing chatter, adding a rates channel that pure-retail comps do not carry.
- No commodity linkage. Cross-border resale flows give some tariff and FX sensitivity, but nothing in the Q2 disclosure quantifies it.
Notes
- GAAP net line diverges sharply from adjusted metrics (Q2 2026: $(27)M net loss vs +$13.5M adj EBITDA) — GMV, revenue and adj EBITDA are the operating read.
- Capital structure carries $231.5M convertible senior notes against $119.1M cash and equivalents as of Q2 2026 (reported 2026-08-06).
- Reference levels: 52-week high $16.90 on the adjusted series; ~$13 is the unbroken range-top shelf; ~$10 is the post-print structural line.
- 2026 insider Form 4 flow found in the record is vesting/tax-withholding sales at $9.25 (May 2026) and director DSU grants — not discretionary open-market selling.
- Analyst book is one-sided: 8-analyst consensus Strong Buy, average target $18.19, low $16, high $20 — every published target sits above the 2026-08-14 close of $11.40.
- Direct revenue (+26% in Q2) is outgrowing consignment revenue (+15%), a mix shift that caps gross margin, which was 74.4% and only +10bps YoY.
Related · shared themes
HUM
Humana Inc.
Margin-over-volume Medicare Advantage reset reclaimed its trend: the 2026-08-24 close of $386.61 is 2.0% above the prior session and back clear of the last 50-day value observed ($378.33, 2026-08-12), with RSI(14) at 64.6 from 52.5. Revision flow idle since Bernstein's 08-14 Buy/$425, and the 2027 number now has a venue — a 2026-12-10 investor update — past both the 09-08/10 conference window and the 11-06 print. The narrative is maturing.
RXO
RXO, Inc.
Freight-cycle recovery intact; sell-side has fully caught up into a $20–35 battleground — bears $20 (Goldman 07-16, Susquehanna 07-14), bulls $30–35 (BMO $35 initiation 07-14, Stifel/Truist/Citi $30). Narrative matured from mispriced to consensus; the ~2026-08-05 Q2 print (adj EBITDA guide $27–37M vs $6M Q1) is the binary the whole re-rate discounts.
CNC
Centene Corporation
Margin-repair guide raise of 2026-07-28 stays fully priced: the 2026-08-24 close of $65.65 is 2.7% under the 2026-08-14 close of $67.47 and 4.5% below the $68.72 52-week high, with no analyst target moved since Argus on 2026-08-11. maturing; the next company-controlled datapoint is Q3, now calendared 2026-10-27.
HNGE
Hinge Health, Inc.
Digital-MSK profitability re-rate broke out in May and was pushed into open price discovery by the 2026-06-09 mid-quarter raise (Q2 to $200–202M, +45%; FY26 to $818–824M). But nine sell-side target hikes in two weeks plus accelerating insider selling mark a late, distribution-prone phase, with no company catalyst until the ~2026-08-04 Q2 print.
See also · stocks to watch